Interphex 2024: ‘ACG focuses on lowering manufacturer’s TCO’

At this year’s Interphex, ACG Engineering, part of ACG - the world's only integrated pharmaceutical solutions and manufacturing company - will be focusing on its cost-effective approach to taking generics to market.

ACG’s methodology is based on speed-to-market, production efficiency and reducing manufacturing costs.

Borja Guerra, vice-president of international sales at ACG, said: “As a highly experienced global supplier of process and packaging machinery of all oral solid dosage requirements, we are attuned to local market requirements. We aim to provide a low TCO (total cost of ownership) for premium pharmaceutical equipment.

“With over six decades of experience partnering in the oral solid dosage space, we have taken over 8000 generics to market, working with more than 1000 pharmaceutical manufacturers to achieve this.”

ACG will be showcasing its ACCURA 100 FF. The capsule checkweigher is designed specifically for precise, automatic, and continuous weighing of each capsule – whether empty, filled or partially filled, with anything from powder to pellets, and which is format free.

ACG is the world’s largest integrated supplier of pharmaceutical and nutraceutical solid dosage products and services.  The company will be exhibiting on stand 3515 between 16-18 April in New York.




About ACG

For over 60 plus years, ACG has been innovating the production solutions for pharmaceutical and nutraceutical companies, that help make people better.

As the world’s most integrated provider of oral dosage products and services, we produce capsules, barrier packaging materials, manufacturing machinery, and visual inspection and traceability solutions. All fully compliant with international standards.

Today, ACG fosters long-term collaborative partnerships with customers in 138 countries across six continents.

Together, we share a common purpose: to solve the world’s greatest health challenges and make it better for everybody we serve.

For more information, please contact the ACG media relations team:


Back to news